1563MO CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity

ABSTRACT:

SUBMITTER: Obermannova R 

PROVIDER: S-EPMC8454423 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature